Cargando…
New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment
Cefepime, a widely used fourth-generation cephalosporin for coverage of both gram-positive and gram-negative bacteria, has been reported to have associated neurological adverse effects. These effects have been seen mostly in patients mostly with impaired renal function, and currently, dosing is base...
Autores principales: | Oyenuga, Mosunmoluwa, Oyenuga, Abayomi, Rauf, Abdul, Balogun, Omotola, Singh, Niranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883526/ https://www.ncbi.nlm.nih.gov/pubmed/33614301 http://dx.doi.org/10.7759/cureus.12689 |
Ejemplares similares
-
Cefepime- Induced Non-Convulsive Status Epilepticus (NCSE)
por: Kim, Ahro, et al.
Publicado: (2013) -
A Rare Case of Lithium-induced Partial Nephrogenic Diabetes Insipidus
por: Rauf, Abdul, et al.
Publicado: (2020) -
Cefepime-Induced Non-Convulsive Status Epilepticus in a Patient with Normal Renal Function
por: Park, Hyeon-Mi, et al.
Publicado: (2016) -
Delayed Diagnosis of an Invisible Seizure: Cefepime-Induced Non-convulsive Status Epilepticus
por: Allihien, Saint-Martin, et al.
Publicado: (2023) -
Immunotherapy and Antiangiogenic Therapy for the Treatment of Patients With Advanced Renal Cell Carcinoma: A Systematic Review and an Updated Network Meta-Analysis of Phase III Clinical Trials
por: Patel, Rushin, et al.
Publicado: (2023)